Works matching Alkylating agents
Results: 4295
Temozolomide and Other Alkylating Agents in Glioblastoma Therapy.
- Published in:
- Biomedicines, 2019, v. 7, n. 3, p. 69, doi. 10.3390/biomedicines7030069
- By:
- Publication type:
- Article
Life-Cycle-Dependent Toxicities of Mono- and Bifunctional Alkylating Agents in the 3R-Compliant Model Organism C. elegans.
- Published in:
- Cells (2073-4409), 2023, v. 12, n. 23, p. 2728, doi. 10.3390/cells12232728
- By:
- Publication type:
- Article
Supported Nickel Nanoparticles as Catalyst in Direct sp<sup>3</sup> C−H Alkylation of 9H‐Fluorene Using Alcohols as Alkylating Agent.
- Published in:
- Chemistry - An Asian Journal, 2025, v. 20, n. 1, p. 1, doi. 10.1002/asia.202400989
- By:
- Publication type:
- Article
Combination Therapy with Immune Checkpoint Inhibitors and Histone Deacetylase Inhibitors or Alkylating Agents.
- Published in:
- Cancer Management & Research, 2024, v. 16, p. 855, doi. 10.2147/CMAR.S464245
- By:
- Publication type:
- Article
Population pharmacokinetic (PK) analysis of laromustine, an emerging alkylating agent, in cancer patients.
- Published in:
- Xenobiotica, 2017, v. 47, n. 5, p. 394, doi. 10.1080/00498254.2016.1201703
- By:
- Publication type:
- Article
Potentiation of alkylating agents by NLCQ-1 or TPZ in vitro and in vivo.
- Published in:
- Journal of Experimental Therapeutics & Oncology, 2008, v. 7, n. 1, p. 261
- By:
- Publication type:
- Article
Potentiation of alkylating agents by NLCQ-1 or TPZ <em>in vitro</em> and <em>in vivo</em>.
- Published in:
- Journal of Experimental Therapeutics & Oncology, 2006, v. 5, n. 4, p. 261
- By:
- Publication type:
- Article
Increased frequency of dicentric chromosomes in therapy-related MDS and AML compared to de novo disease is significantly related to previous treatment with alkylating agents and suggests a specific susceptibility to chromosome breakage at the centromere.
- Published in:
- Leukemia (08876924), 2000, v. 14, n. 1, p. 105, doi. 10.1038/sj.leu.2401594
- By:
- Publication type:
- Article
Alkylating agents are possible inducers of glioblastoma and other brain tumors.
- Published in:
- Human & Experimental Toxicology, 2024, v. 43, p. 1, doi. 10.1177/09603271241256598
- By:
- Publication type:
- Article
Alkylating Agent-Induced High Tumor Mutational Burden in Medullary Thyroid Cancer and Response to Immune Checkpoint Inhibitors: Two Case Reports.
- Published in:
- Thyroid, 2023, v. 33, n. 11, p. 1368, doi. 10.1089/thy.2023.0144
- By:
- Publication type:
- Article
PQQ Dietary Supplementation Prevents Alkylating Agent-Induced Ovarian Dysfunction in Mice.
- Published in:
- Frontiers in Endocrinology, 2022, v. 13, p. 1, doi. 10.3389/fendo.2022.781404
- By:
- Publication type:
- Article
Alkylating agents in membranous nephropathy: efficacy proven beyond doubt.
- Published in:
- 2010
- By:
- Publication type:
- Editorial
Multi-Omics Analysis of NCI-60 Cell Line Data Reveals Novel Metabolic Processes Linked with Resistance to Alkylating Anti-Cancer Agents.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 17, p. 13242, doi. 10.3390/ijms241713242
- By:
- Publication type:
- Article
Docking analysis of aryl derivatives of diepoxide alkylating agents.
- Published in:
- Pakistan Journal of Pharmaceutical Sciences, 2020, v. 33, n. 5, p. 2017, doi. 10.36721/PJPS.2020.33.5.REG.2017-2021.1
- By:
- Publication type:
- Article
In vitro testing of drug combinations employing nilotinib and alkylating agents with regard to pretransplant conditioning treatment of advanced-phase chronic myeloid leukemia.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2014, v. 74, n. 2, p. 427, doi. 10.1007/s00280-014-2533-6
- By:
- Publication type:
- Article
Les alkylants.
- Published in:
- Oncologie (Tech Science Press), 2007, v. 9, n. 11, p. 751, doi. 10.1007/s10269-007-0785-z
- By:
- Publication type:
- Article
Aldolase A and Phospholipase D1 Synergistically Resist Alkylating Agents and Radiation in Lung Cancer.
- Published in:
- Frontiers in Oncology, 2022, v. 11, p. 1, doi. 10.3389/fonc.2021.811635
- By:
- Publication type:
- Article
Effect of Previous Alkylating Agent Exposure on Follicle Numbers in Cryopreserved Prepubertal and Young Adult Ovarian Tissue after Long-Term Xenografting.
- Published in:
- Cancers, 2022, v. 14, n. 2, p. 399, doi. 10.3390/cancers14020399
- By:
- Publication type:
- Article
Dosage time affects alkylating agents induced micronuclei in mouse peripheral blood reticulocytes through the function of erythropoietin.
- Published in:
- Journal of Toxicological Sciences, 2019, v. 44, n. 4, p. 273, doi. 10.2131/jts.44.273
- By:
- Publication type:
- Article
Mechanism of Action and Use of Radiomimetic Compounds: Part 1 - Alkylating Agents and Antimetabolites.
- Published in:
- Military Engineer / Hadmérnök, 2022, v. 17, n. 1, p. 101, doi. 10.32567/hm.2022.1.7
- By:
- Publication type:
- Article
Antigenotoxic Effects of Citrus aurenfium L. Fruit Peel Oil on Mutagenicity of Two Alkylating Agents and Two Metals in the Drosophila Wing Spot Test.
- Published in:
- Environmental & Molecular Mutagenesis, 2009, v. 50, n. 6, p. 483, doi. 10.1002/em.20484
- By:
- Publication type:
- Article
Kinetks of γ-H2AX Focus Formation Upon Treatment of Cells With UV Light and Alkylating Agents.
- Published in:
- Environmental & Molecular Mutagenesis, 2008, v. 49, n. 9, p. 734, doi. 10.1002/em.20430
- By:
- Publication type:
- Article
Chemotherapy with Alkylating Agents and Dental Anomalies in Children: A Systematic Review.
- Published in:
- Journal of Clinical Medicine, 2025, v. 14, n. 3, p. 1030, doi. 10.3390/jcm14031030
- By:
- Publication type:
- Article
Temozolomide in Glioblastoma Therapy: Role of Apoptosis, Senescence and Autophagy. Comment on Strobel et al., Temozolomide and Other Alkylating Agents in Glioblastoma Therapy. Biomedicines 2019, 7, 69.
- Published in:
- 2019
- By:
- Publication type:
- Letter
Deregulation of homologous recombination DNA repair in alkylating agent-treated stem cell clones: a possible role in the aetiology of chemotherapy-induced leukaemia.
- Published in:
- Oncogene, 2006, v. 25, n. 12, p. 1709, doi. 10.1038/sj.onc.1209208
- By:
- Publication type:
- Article
Efficacy and toxicity of the combination chemotherapy of thalidomide, alkylating agent, and steroid for relapsed/refractory myeloma patients: a report from the Korean Multiple Myeloma Working Party (KMMWP) retrospective study.
- Published in:
- Cancer Medicine, 2017, v. 6, n. 1, p. 100, doi. 10.1002/cam4.970
- By:
- Publication type:
- Article
Autologous stem cell transplantation using modified TAM or combination of triple-alkylating agents conditioning regimens as one of the post-remission treatments in patients with adult acute myeloid leukemia in first complete remission.
- Published in:
- Bone Marrow Transplantation, 2004, v. 34, n. 3, p. 215, doi. 10.1038/sj.bmt.1704556
- By:
- Publication type:
- Article
Dose–Effect Relationship of Alkylating Agents on Testicular Function in Male Survivors of Childhood Lymphoma.
- Published in:
- Pediatric Hematology & Oncology, 2015, v. 32, n. 8, p. 613, doi. 10.3109/08880018.2015.1085933
- By:
- Publication type:
- Article
Gemcitabine and oxaliplatin or alkylating agents for neuroendocrine tumors: Comparison of efficacy and search for predictive factors guiding treatment choice.
- Published in:
- 2015
- By:
- Publication type:
- journal article
AMPK mediates a pro-survival autophagy downstream of PARP-1 activation in response to DNA alkylating agents
- Published in:
- FEBS Letters, 2013, v. 587, n. 2, p. 170, doi. 10.1016/j.febslet.2012.11.018
- By:
- Publication type:
- Article
Novel MGMT inhibitors increase the sensitivity of glioma MGMT-positive cells to treatment with alkylating agents in vitro.
- Published in:
- Biopolymers & Cell, 2024, v. 40, n. 1, p. 47, doi. 10.7124/bc.000AAD
- By:
- Publication type:
- Article
Epitaxial Growth of a Thin Layer of Putative Cancer Cells under Limited Resources and in the Presence of an Alkylating Agent.
- Published in:
- Nonlinear Dynamics, Psychology & Life Sciences, 2022, v. 26, n. 2, p. 131
- By:
- Publication type:
- Article
Structure-activity study of the interaction of bioreductive benzoquinone alkylating agents with DNA topoisomerase II.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2006, v. 57, n. 2, p. 221, doi. 10.1007/s00280-005-0040-5
- By:
- Publication type:
- Article
Structure-activity study with bioreductive benzoquinone alkylating agents: effects on DT-diaphorase-mediated DNA crosslink and strand break formation in relation to mechanisms of cytotoxicity.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2004, v. 53, n. 3, p. 191, doi. 10.1007/s00280-003-0718-5
- By:
- Publication type:
- Article
Preparation and Chemical Behavior of 2‐(tert‐Butoxycarbonyl)amino‐3‐bromomethyl Pyridine, a Novel Alkylating Agent.
- Published in:
- Synthetic Communications, 2006, v. 36, n. 2, p. 181, doi. 10.1080/00397910500334371
- By:
- Publication type:
- Article
Stimulatory and Protective Effects of Alkylating Agents Applied in Ultra-Low Concentrations.
- Published in:
- Pharmacology, 2001, v. 62, n. 3, p. 129, doi. 10.1159/000056084
- By:
- Publication type:
- Article
Alkylating Agent-Induced Toxicity and Melatonin-Based Therapies.
- Published in:
- Frontiers in Pharmacology, 2022, v. 13, p. 1, doi. 10.3389/fphar.2022.873197
- By:
- Publication type:
- Article
Novel Pathways of Oxidative and Nitrosative Inactivation of the Human MGMT Protein in Colon Cancer and Glioblastoma Cells: Increased Efficacy of Alkylating Agents In Vitro and In Vivo.
- Published in:
- Diseases, 2025, v. 13, n. 2, p. 32, doi. 10.3390/diseases13020032
- By:
- Publication type:
- Article
Commonly Used Alkylating Agents Limit Persulfide Detection by Converting Protein Persulfides into Thioethers.
- Published in:
- Angewandte Chemie, 2022, v. 134, n. 30, p. 1, doi. 10.1002/ange.202203684
- By:
- Publication type:
- Article
253. BTC, A HUMAN P450 CONTAINING ESCHERICHIA COLI TESTER STRAIN WITH A HIGH SENSITIVITY TOWARDS ALKYLATING AGENTS.
- Published in:
- 2003
- Publication type:
- Abstract
Induction of an adaptive response in Drosophila imaginal disc cells exposed in vivo to low doses of alkylating agents.
- Published in:
- Mutagenesis, 2000, v. 15, n. 4, p. 337, doi. 10.1093/mutage/15.4.337
- By:
- Publication type:
- Article
DNA repair methyltransferase (Mgmt) knockout mice are sensitive to the lethal effects of chemotherapeutic alkylating agents.
- Published in:
- Mutagenesis, 1999, v. 14, n. 3, p. 339, doi. 10.1093/mutage/14.3.339
- By:
- Publication type:
- Article
Histone H2AX is a critical factor for cellular protection against DNA alkylating agents.
- Published in:
- Oncogene, 2008, v. 27, n. 43, p. 5662, doi. 10.1038/onc.2008.187
- By:
- Publication type:
- Article
N-methylpurine DNA glycosylase inhibits p53-mediated cell cycle arrest and coordinates with p53 to determine sensitivity to alkylating agents.
- Published in:
- Cell Research, 2012, v. 22, n. 8, p. 1285, doi. 10.1038/cr.2012.107
- By:
- Publication type:
- Article
Reichardt's dye and its reactions with the alkylating agents 4-chloro-1-butanol, ethyl methanesulfonate, 1-bromobutane and Fast Red B – a potentially useful reagent for the detection of genotoxic impurities in pharmaceuticals.
- Published in:
- Journal of Pharmacy & Pharmacology, 2009, v. 61, n. 4, p. 533, doi. 10.1211/jpp.61.04.0017
- By:
- Publication type:
- Article
HLA-DR7 predicts the response to alkylating agents in steroid-sensitive nephrotic syndrome.
- Published in:
- Pediatric Nephrology, 1997, v. 11, n. 1, p. 16, doi. 10.1007/s004670050224
- By:
- Publication type:
- Article
A simplified approach to stem cell mobilization in multiple myeloma patients not previously treated with alkylating agents.
- Published in:
- Bone Marrow Transplantation, 2003, v. 32, n. 12, p. 1113, doi. 10.1038/sj.bmt.1704286
- By:
- Publication type:
- Article
Intracellular activation of 4-hydroxycyclophosphamide into a DNA-alkylating agent in human leucocytes.
- Published in:
- Xenobiotica, 2021, v. 51, n. 10, p. 1188, doi. 10.1080/00498254.2021.1975060
- By:
- Publication type:
- Article
Use of 4-(nitrobenzyl)pyridine (4-nbp) to test mutagenic potential of slow-reacting epoxides, their corresponding olefins, and other alkylating agents.
- Published in:
- Bulletin of Environmental Contamination & Toxicology, 1992, v. 49, n. 6, p. 879, doi. 10.1007/BF00203162
- By:
- Publication type:
- Article
Cytotoxic and apoptotic effects of bortezomib and gefitinib compared to alkylating agents on human glioblastoma cells.
- Published in:
- Journal of Experimental Therapeutics & Oncology, 2008, v. 7, n. 2, p. 99
- By:
- Publication type:
- Article